Jeffrey H Albrecht

Jeffrey H Albrecht is a Professor of Medicine at the University of Minnesota, affiliated with the Division of Gastroenterology, Hepatology, and Nutrition within the Medical School. His research centers on the cellular and molecular mechanisms of liver regeneration and cancer, with a particular focus on the role of cyclin D1 and CDK4 in hepatocyte proliferation and metabolic reprogramming.

His research interests span liver biology, cell cycle regulation, hepatocellular carcinoma, liver homeostasis, metabolic reprogramming in cancer, and epigenetic control in hepatoblastoma. His work integrates molecular biology, cell signaling, and metabolic analysis to understand how hepatocytes balance proliferation and function. He has made significant contributions to understanding how cyclin D1 regulates both the cell cycle and metabolic pathways in the liver, particularly in regeneration and cancer contexts.

Analysis of his recent publications (2020–2023) reveals a strong trend toward interdisciplinary research combining molecular oncology, metabolism, and clinical hepatology. His articles in high-impact journals like Science and PNAS highlight discoveries in liver zonation, epigenetic switches in cancer, and metabolic reprogramming. His work increasingly bridges basic science with translational applications, including clinical trials on statins in cirrhosis.

• Principal Investigator, NIH-funded project: Cyclin D1/CDK4 Complex in Hepatocyte Proliferation (2015–2020)

Dr. Albrecht has led significant research projects and collaborates widely with experts in hepatology, oncology, and metabolism. While specific student advisees are not listed, his role as a principal investigator and frequent co-author on major studies indicates active mentorship and team leadership. He has no explicitly listed scientific awards in the provided text, but his publication record and NIH funding reflect recognition in the field.

His research is conducted within a collaborative network focused on liver disease and cancer, likely involving laboratory teams and clinical collaborators at the University of Minnesota and beyond. His work contributes to global efforts in liver health and sustainable development goals related to health and well-being.